Hippo (NYSE: HIPO) insider files to sell 6,105 shares under Rule 144

Rhea-AI Filing Summary

Hippo (HIPO) insider Torben Ostergaard has filed a Rule 144 notice to sell 6,105 shares of the company’s common stock. The planned sale, through Morgan Stanley Smith Barney on the NYSE, has an aggregate market value of $172,527.30 based on the figures in the notice.

The filing states that 25,335,179 shares of common stock were outstanding. It also discloses that over the prior three months, a Rule 10b5-1 plan sale of 3,645 common shares generated gross proceeds of $116,592.06. The signer represents they are not aware of undisclosed material adverse information about Hippo.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6105	172527.30	25335179	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Restricted Stock Units	Issuer			6105	08/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for TORBEN OSTERGAARD One Almaden Blvd., Suite 400 San Jose CA 95113	Common	11/21/2025	3645	116592.06

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Hippo (HIPO) Form 144 filed by Torben Ostergaard disclose?

The Form 144 discloses an intent to sell 6,105 Hippo common shares. The proposed sale, listed at an aggregate market value of $172,527.30, will be executed through Morgan Stanley Smith Barney on the NYSE, subject to Rule 144 conditions.

How many Hippo (HIPO) shares are planned to be sold under this Rule 144 notice?

The notice covers a proposed sale of 6,105 Hippo common shares. These shares were acquired as restricted stock units on August 15, 2025, and are scheduled for sale around February 17, 2026, through a broker on the NYSE.

What prior Hippo (HIPO) share sales are reported in the last three months?

The filing reports a prior Rule 10b5-1 sale of 3,645 Hippo common shares. That transaction generated gross proceeds of $116,592.06 and is attributed to 10b5-1 sales for Torben Ostergaard during the past three months.

What is the reported market value of the planned Hippo (HIPO) share sale?

The planned sale of 6,105 Hippo common shares carries an aggregate market value of $172,527.30. This figure reflects the value used in the Rule 144 notice for the proposed NYSE transaction through Morgan Stanley Smith Barney.

How many Hippo (HIPO) shares are reported as outstanding in the Form 144?

The notice states that 25,335,179 Hippo common shares were outstanding. This number provides context for the size of the proposed 6,105-share Rule 144 sale relative to the issuer’s total common stock base.

What representation does the Hippo (HIPO) Form 144 signer make about company information?

The signer represents that they do not know any material adverse information about Hippo’s current or prospective operations that has not been publicly disclosed. This representation is required when filing a Rule 144 notice to sell restricted or control securities.